The Use of Palliative Whole Brain Radiotherapy in the Management of Brain Metastases

Clinical Oncology

Volumn 24, Issue 10, 2012, Pages

  Kong, W ^a   Jarvis, C R ^a   Sutton, D S ^a,b   Ding, K ^b   Mackillop, W J ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Access; Brain metastasis; Palliative radiotherapy; Population based; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; COLON CANCER; FATALITY; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYELOMA; PALLIATIVE THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SOCIAL STATUS; STOMACH CANCER; WHOLE BRAIN RADIOTHERAPY;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SOCIAL CLASS; SURVIVAL RATE;

EID: 84868304282     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.08.004     Document Type: Article

References (66)

1. DeAngelis L.M., Posner J.B. Neurologic complications of cancer 2009, Oxford University Press, New York.
2. Gavrilovic I.T., Posner J.B. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005, 75:5-14.
3. Lassman A.B., DeAngelis L.M. Brain metastases. Neurol Clin 2003, 21:1-23.
4. Posner J.B., Chernik N.L. Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:579-592.
5. Schouten L.J., Rutten J., Huveneers H.A., Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94:2698-2705.
6. Barnholtz-Sloan J.S., Sloan A.E., Davis F.G., Vigneau F.D., Lai P., Sawaya R.E. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22:2865-2872.
7. Cairncross J.G., Kim J.H., Posner J.B. Radiation therapy for brain metastases. Ann Neurol 1980, 7:529-541.
8. Nguyen T.D., DeAngelis L.M. Brain metastases. Neurol Clin 2007, 25:1173-1192.
9. Nussbaum E.S., Djalilian H.R., Cho K.H., Hall W.A. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781-1788.
10. Posner J.B. Brain metastases: 1995. A brief review. J Neurooncol 1996, 27:287-293.
11. Zimm S., Wampler G.L., Stablein D., Hazra T., Young H.F. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981, 48:384-394.
12. Tsao M.N., Lloyd N., Wong R., Chow E., Rakovitch E., Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006, 3:003869.
13. Tsao M.N., Lloyd N.S., Wong R.K., et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005, 31:256-273.
14. Expert Panel on Radiation Oncology-Brain, Metastases, Videtic G.M., Gaspar L.E., et al. American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys 2009, 75:961-965.
15. Tsao M.N., Lloyd N.S., Wong R.K. Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care. Clinical practice guideline on the optimal radiotherapeutic management of brain metastases. BMC Cancer 2005, 5:34.
16. Mulvenna P.M. The management of brain metastases in patients with non-small cell lung cancer - is it time to go back to the drawing board?. Clin Oncol (R Coll Radiol) 2010, 22:365-373.
17. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
18. Sperduto P.W., Berkey B., Gaspar L.E., Mehta M., Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
19. Nieder C., Pawinski A., Molls M. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?. Clin Oncol (R Coll Radiol) 2010, 22:65-69.
20. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
21. Wong J., Hird A., Zhang L., et al. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75:1125-1131.
22. Wong J., Hird A., Kirou-Mauro A., Napolskikh J., Chow E. Quality of life in brain metastases radiation trials: a literature review. Curr Oncol 2008, 15:25-45.
23. Khuntia D., Brown P., Li J., Mehta M.P. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006, 24:1295-1304.
24. Witgert M.E., Meyers C.A. Neurocognitive and quality of life measures in patients with metastatic brain disease. Neurosurg Clin North Am 2011, 22:79-85.
25. Bezjak A., Adam J., Barton R., et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002, 38:487-496.
26. Chow E., Davis L., Holden L., Tsao M., Danjoux C. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 2005, 30:18-23.
27. Doyle M., Bradley N.M., Li K., et al. Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy. J Palliat Med 2007, 10:367-374.
28. Gerrard G.E., Prestwich R.J., Edwards A., et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol) 2003, 15:422-428.
29. Yaneva M.P., Semerdjieva M.A. Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QOL-C30 questionnaire. Folia Med (Plovdiv) 2006, 48:23-29.
30. Scott C., Suh J., Stea B., Nabid A., Hackman J. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases. Am J Clin Oncol 2007, 30:580-587.
31. Addeo R., Caraglia M., Faiola V., et al. Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer 2007, 7:18.
32. Brown P.D., Asher A.L., Farace E. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. Int J Radiat Oncol Biol Phys 2008, 70:1305-1309.
33. Chang E.L., Wefel J.S., Hess K.R., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
34. Regine W.F., Scott C., Murray K., Curran W. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 2001, 51:711-717.
35. Marko N.F., Weil R.J. Radiotherapy: neurocognitive considerations in the treatment of brain metastases. Nat Rev Clin Oncol 2010, 7:185-186.
36. Meyers C.A., Smith J.A., Bezjak A., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004, 22:157-165.
37. Li J., Bentzen S.M., Renschler M., Mehta M.P. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007, 25:1260-1266.
38. Li J., Bentzen S.M., Li J., Renschler M., Mehta M.P. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 2008, 71:64-70.
39. Mackillop W.J., Groome P.A., Zhang-Solomons J., et al. Does a centralized radiotherapy system provide adequate access to care?. J Clin Oncol 1997, 15:1261-1271.
40. Sutton D.S., Kong W., Ding K., Mackillop W.J. The use of palliative radiotherapy for bone metastasis. Radiother Oncol 2010, 97:548-553.
41. Huang J., Zhou S., Groome P., Tyldesley S., Zhang-Solomans J., Mackillop W.J. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 2001, 19:137-144.
42. Robles S.C., Marrett L.D., Clarke E.A., Risch H.A. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 1988, 41:495-501.
43. Clarke E.A., Marrett L.D., Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ 1991, 246-257.
44. Kong W., Zhang-Salomons J., Hanna T.P., Mackillop W.J. A population-based study of the fractionation of palliative radiotherapy for bone metastasis in Ontario. Int J Radiat Oncol Biol Phys 2007, 69:1209-1217.
45. Mackillop W.J., Fu H., Quirt C.F., Dixon P., Brundage M., Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994, 30:221-228.
46. Mackillop W.J., Zhang-Salomons J., Groome P.A., Paszat L., Holowaty E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol 1997, 15:1680-1689.
47. Johnston G.M., Boyd C.J., Joseph P., MacIntyre M. Variation in delivery of palliative radiotherapy to persons dying of cancer in Nova Scotia, 1994 to 1998. J Clin Oncol 2001, 19:3323-3332.
48. Paszat L.F., Mackillop W.J., Groome P.A., Zhang-Salomons J., Schulze K., Holowaty E. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 1998, 21:125-134.
49. Townsley C., Pond G.R., Peloza B., et al. Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol 2005, 23:3802-3810.
50. Tyldesley S., Zhang-Salomons J., Groome P.A., et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 2000, 47:469-480.
51. Danielson B., Winget M., Gao Z., Murray B., Pearcey R. Palliative radiotherapy for women with breast cancer. Clin Oncol (R Coll Radiol) 2008, 20:506-512.
52. Wu J.S., Kerba M., Wong R.K., Mckimmon E., Eigl B., Hagen N.A. Patterns of practice in palliative radiotherapy for painful bone metastases: impact of a regional rapid access clinic on access to care. Int J Radiat Oncol Biol Phys 2010, 78:533-538.
53. Hayman J.A., Abrahamse P.H., Lakhani I., Earle C.C., Katz S.J. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 69:1001-1007.
54. de Rijke J.M., Schouten L.J., Schouten H.C., Jager J.J., Koppejan A.G., van den Brandt P.A. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol 1996, 7:677-685.
55. Wasil T., Lichtman S.M., Gupta V., Rush S. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000, 23:526-530.
56. Zachariah B., Balducci L., Venkattaramanabalaji G.V., Casey L., Greenberg H.M., DelRegato J.A. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997, 39:1125-1129.
57. Zachariah B., Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin North Am 2000, 14:131-167.
58. Brown J.S., Eraut D., Trask C., Davison A.G. Age and the treatment of lung cancer. Thorax 1996, 51:564-568.
59. Peake M.D., Thompson S., Lowe D., et al. Ageism in the management of lung cancer. Age Ageing 2003, 32:171-177.
60. Samant R.S., Fitzgibbon E., Meng J., Graham I.D. Barriers to palliative radiotherapy referral: a Canadian perspective. Acta Oncol 2007, 46:659-663.
61. Gripp S., Mjartan S., Boelke E., Willers R. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?. Cancer 2010, 116:3251-3256.
62. Mackillop W.J., Quirt C.F. Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol 1997, 50:21-29.
63. Athas W.F., Adams-Cameron M., Hunt W.C., Amir-Fazli A., Key C.R. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000, 92:269-271.
64. Pagano E., Di Cuonzo D., Bona C., et al. Accessibility as a major determinant of radiotherapy underutilization: a population based study. Health Policy 2007, 80:483-491.
65. Nieder C., Norum J., Spanne O., Bilberg I., Vagstad G., Dalhaug A. Does distance to treatment centre influence the rate of palliative radiotherapy in adult cancer patients?. Anticancer Res 2009, 29:2641-2644.
66. Smedby K.E., Brandt L., Backlund M.L., Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 2009, 101:1919-1924.